Lexicon Pharmaceuticals develops therapeutic products for diseases relating to immunology, metabolism, cardiology and ophthalmology.
Veracyte is a company that develops molecular diagnostic tests for thyroid and non-small cell lung cancer.
Myriad Genetics is a molecular diagnostic company which focuses on developing and marketing novel predictive medicine, personalized medicine, and prognostic medicine tests.
Invitae is a company engaged in medical genetic testing.
NanoString Technologies is a provider of life science tools for translational research and molecular diagnostics.
Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them.
Cancer Genetics, Inc. (CGI) provides DNA-based cancer diagnostics and services to medical institutions.
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Natera (formerly known as Gene Security Network) is a genetic testing company that operates a CLIA-certified laboratory.
Adverum Biotechnologies (formerly known as Avalanche Biotechnologies) is a clinical-stage gene therapy company targeting unmet medical need in ophthalmology and rare diseases.
Bluebird Bio offers products based on the transformative potential of gene therapy for patients with genetic and orphan diseases.
23andMe is a consumer genetics and research company.